Paracetamol remains the most consumed analgesic in France, often perceived as harmless. However, its relationship with blood pressure and the vagal nervous system deserves careful consideration of the available clinical data. What increase in blood pressure is measured during regular use, and can this phenomenon interact with a predisposition to vagal discomfort?
Effect of paracetamol on blood pressure: what the PATH-BP trial measured
The randomized PATH-BP trial, conducted by the University of Edinburgh and published in the journal Circulation in 2022, is the most robust reference on the subject. The protocol was rigorous: a crossover, double-blind, placebo-controlled study in hypertensive adults.
Participants took one gram of paracetamol four times a day for fourteen days. Systolic blood pressure increased statistically significantly compared to placebo. The observed increase disappeared after stopping the treatment, indicating a reversible effect rather than persistent vascular damage.
To fully understand the impact of paracetamol on vagal discomfort, it is essential to distinguish between occasional use (one tablet for transient pain) and regular consumption over several days, which is the only situation where the blood pressure effect has been documented.
| Parameter | Paracetamol (1 g x 4/day, 14 days) | Placebo |
|---|---|---|
| Studied population | Hypertensive adults | Hypertensive adults |
| Protocol duration | 14 days | 14 days |
| Effect on systolic pressure | Significant increase | No increase |
| Reversibility after stopping | Yes | Not applicable |
| Study design | Randomized, crossover, double-blind | Randomized, crossover, double-blind |
Vagal discomfort and blood pressure: two distinct mechanisms
Vagal discomfort results from excessive activation of the vagus nerve, leading to a slowing of the heart rate (bradycardia) and a drop in blood pressure. The classic symptoms (sweating, nausea, blurred vision, loss of consciousness) directly stem from this abrupt decrease in cerebral blood flow.
Paracetamol, on the other hand, acts through a different pharmacological mechanism. Its blood pressure effect, documented in the PATH-BP trial, involves a moderate increase in systolic blood pressure during prolonged use. The two phenomena do not share the same physiological pathways.
Why confusion persists
Many patients associate any medication affecting blood pressure with a risk of discomfort. The logic seems intuitive: if paracetamol alters blood pressure, it could trigger or worsen vagal discomfort. However, current clinical data do not show a direct link between paracetamol use and the occurrence of a vagal episode.
Vagal discomfort is triggered by specific stimuli:
- Prolonged standing, heat, dehydration, which reduce venous return to the heart
- Reflex vagal stimulation (intense pain, sight of blood, abdominal straining)
- Orthostatic hypotension in the elderly or those on antihypertensive treatment
None of these triggering factors are related to the mechanism by which paracetamol raises blood pressure.
Treated hypertension and risk of vagal discomfort: the real point of vigilance
The intersection of paracetamol and vagal discomfort becomes relevant in a specific situation: that of the hypertensive patient treated with antihypertensive medications who also regularly takes paracetamol.
The 2025 AHA/ACC recommendations emphasize the individualization of blood pressure targets in individuals with symptomatic orthostatic hypotension or significant frailty. A patient whose blood pressure is lowered by antihypertensive treatment may find themselves in a zone where even the slightest additional factor (dehydration, standing, heat) is enough to trigger vagal discomfort.
In this context, the question is not whether paracetamol causes discomfort, but whether the overall management of blood pressure (antihypertensive treatment, analgesic consumption, hydration) is coherent. The treating physician remains the only one able to assess this balance.
Paracetamol for occasional or prolonged use: different risks
The synthesis published by Minerva in 2023 highlights a point often overlooked in the mainstream press: data primarily show an increase in blood pressure in patients already hypertensive with regular use. The exact clinical impact for the general population remains insufficiently established.
For an adult without cardiovascular history who takes a paracetamol tablet for an occasional headache, no data suggest a measurable blood pressure risk. However, daily consumption over several days warrants particular attention, especially in the presence of cardiac risk factors.
What changes concretely for the patient
- Occasional use (one to two days): no blood pressure alert signal in the available literature
- Regular use (more than a week) in a hypertensive patient: blood pressure monitoring recommended by the physician
- Patient prone to vagal discomfort: no specific contraindication to paracetamol, but consultation useful if episodes recur under analgesic treatment
- Any modification of antihypertensive treatment associated with regular paracetamol use deserves close medical follow-up
Paracetamol is not an identified trigger of vagal discomfort. Its effect on blood pressure, documented by the PATH-BP trial, concerns prolonged use in hypertensive patients and proves reversible upon cessation. For individuals prone to vagal episodes, the determining factor remains the overall management of blood pressure, not the analgesic taken in isolation.
